Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mathew Voisin"'
Autor:
Yasin Mamatjan, Mathew Voisin, Farshad Nassiri, Mira Salih, Fabio Y. Moraes, Severa Bunda, Risalet Tursun, Andreas von Deimling, Kenneth D. Aldape, Gelareh Zadeh
Publikováno v:
2022 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB).
Autor:
Zsolt Zador, Nicholas Mikolajewicz, Hong Han, Mathew Voisin, Chitra Venugopal, Chirayu Chokshi, Will Maich, Moffat Jason, Gelareh Zadeh, Sheila Singh
Publikováno v:
Neuro-Oncology. 24:vii291-vii292
Persister states are proposed oncogenic substrates of disease recurrence in cancer. Recent concepts suggest persisters may occur in dynamic states of the cell cycle (such as cycling and non-cycling states). We therefore investigated biological progra
TMIC-73. HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA
Autor:
Sheila Mansouri, Mark Zaidi, Olivia Singh, Hafsah Ali, Shirin Karimi, Phoebe Lombard, Anna Dvorkin-Gheva, Carlos Velasquez, Kaviya Devaraja, Julio Sosa, Vikas Patil, Qingxia Wei, Ronald Wu, Mira Li, May Cheung, Mathew Voisin, Andrew Gao, David Hedley, Kenneth Aldape, Bradly Wouters, Gelareh Zadeh
Publikováno v:
Neuro-Oncology. 24:vii287-vii288
Rapidly growing solid tumors such as glioblastoma (GBM) are characteristically hypoxic, displaying large areas of necrosis surrounded by hyperproliferative pseudopalisading cells. Intra-tumoral hypoxia develops over time in the three-dimensional spac
Autor:
Jeffrey A Zuccato, Vikas Patil, Sheila Mansouri, Mathew Voisin, Ankur Chakravarthy, Shu Yi Shen, Farshad Nassiri, Nicholas Mikolajewicz, Mara Trifoi, Anna Skakodub, Brad Zacharia, Michael Glantz, Daniel D De Carvalho, Alireza Mansouri, Gelareh Zadeh
Publikováno v:
Neuro-oncology.
Background Resolving the differential diagnosis between brain metastases (BM), glioblastomas (GBM), and central nervous system lymphomas (CNSL) is an important dilemma for the clinical management of the main three intra-axial brain tumor types. Curre
Publikováno v:
Neuro Oncol
BACKGROUND An increasing number of elderly patients are being diagnosed with GBM and undergoing surgery. These patients often present with multiple medical comorbidities and have significantly worse outcomes compared to adult patients. The goal of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b6516ff086c7a1f81d8e82ae817f3c2
https://europepmc.org/articles/PMC8598563/
https://europepmc.org/articles/PMC8598563/
Publikováno v:
Neuro-Oncology. 24:vii154-vii154
PURPOSE Isocitrate dehydrogenase (IDH) mutation status is a key diagnostic and prognostic feature of gliomas. It is thought to occur early in glioma tumorigenesis and remains stable over time. We investigated our tumour bank to identify patients wher
Publikováno v:
Neuro-Oncology. 24:vii199-vii199
OBJECTIVE The role of surgery in recurrent GBM remains a controversial topic. The goal of this study was to perform a case-control analysis including time to tumor recurrence as an additional prognostic factor in order to determine which patients ben
Autor:
Justin Wang, Alexander Landry, Farshad Nassiri, Grace Lee, Lauren Rogers, Jeffrey Zuccato, Mathew Voisin, David Munoz, Derek Tsang, Normand Laperriere, Gelareh Zadeh
Publikováno v:
Neuro-Oncology. 24:vii55-vii55
BACKGROUND Meningiomas are the most common primary brain tumour, and patients requiring intervention typically undergo surgical resection as first-line therapy. However, fractionated radiotherapy (fRT) as primary treatment remains an option for patie
Autor:
Matthijs van der Meulen, Ronald Ramos, Mathew Voisin, Vikas Patil, Qingxia Wei, Olivia Singh, Seth Climans, Navya Kalidindi, Rosamarylin Or, Phideas Diamandis, David Munoz, Gelareh Zadeh, Warren Mason
Publikováno v:
Neuro-Oncology. 24:vii156-vii156
INTRODUCTION Patients with glioblastomas (GBM) have an overall survival (OS) of approximately 15 months. However, approximately 5% of patients survive much longer, with an OS of > 5 years. This study examines the differences in methylation profiles b
Publikováno v:
Neuro-oncology Advances
Background Glioblastoma (GBM) has a median age of diagnosis of 64 years old and the incidence increases with age. An increasing number of elderly patients are being diagnosed with GBM and undergoing surgery. These patients often present with multiple